Pioneered a revolutionary new process for
the manufacture of Metronidazole from its basic stage.
2002
Two product patents from US Patent & Trade mark office for topical
application of Metronidazole and PVP iodine.
2002
Second company in India to receive Drug controller General of India’s
permission to market Ofloxacin Once-Daily 400mg & 800mg Formulations.
2002
J.B.Chemicals & Pharmaceuticals Ltd. is the first Indian and Asian
Company to obtain the prestigious new EP4 European Certification for
its Active Pharmaceutical Ingredient (API) – Nifedipine, Metronidazole
& Diclofenac Sodium.
2000
Two product patents from US Patent & Trade mark office for Dental
Formulations
1999
Developed several novel formulations, the significant ones being Metrogyl
Denta and Metrogyl V Gel.
1998
US Patent for novel pharmaceuticals formulation of
Metronidazole for Dental application.
1996
Patent for Controlled Release Formulation of Nifedipine
in South Africa, Kazakhstan and Czech Republic.
1996
Patent of Doktor Mom Herbal Cough Remedy in Russia
and Kazakhstan.
1995 / 1996
Patent of Controlled Release Formulation of Ranitidine
in USA and South Africa.
1990
Developed several Sustained Release Formulations like Dilcardia SR,
Dicloran SR and Beta Nicardia
1990
Pioneered the development of Diclofenac Sodium (bromine
free) from its basic stage.
1985
First in India to use Form-Fill-Seal Technology for Metrogyl IV.
1985
First to develop Nicardia Retard and Nicardia
CD, Sustained Release Formulations of Nifedipine.
1985
Pioneered the development of Nifedipine from its
basic stage.
1983
Pioneered the development of Glyoxal (40%)
from its basic stage.
1974
Developed Ifiral, a Sodium Cromoglycate formulations,
widely recognized as an excellent prophylactic for asthma patients.
|